Global Fast-Absorption Bioabsorbable Stents Market Size By Application,By Material, By End User, By Geographic Scope And Forecast

Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Fast- absorption Bioabsorbable Stents Market Size And Forecast

Fast- absorption Bioabsorbable Stents Market size was valued at USD 375.8 Million in 2023 and is projected to reach USD 560.7 Million by 2030, growing at a CAGR of 6.4% during the forecast period 2024-2030.

Global Fast- absorption Bioabsorbable Stents Market Drivers

The market drivers for the Fast- absorption Bioabsorbable Stents Market can be influenced by various factors. These may include

  • Technological DevelopmentsFast-absorption bioabsorbable stents with enhanced qualities, including quicker absorption rates, better mechanical performance, and a lower risk of problems, have been made possible by developments in material science and medical device technology.
  • Decreased Long-Term ComplicationsBecause bioabsorbable stents are absorbed by the body gradually, they do not require long-term dual antiplatelet treatment (DAPT) and do not have the same risk of restenosis and late stent thrombosis as permanent metallic stents.
  • Growing Prevalence of Cardiovascular disordersTo meet the needs of the expanding patient population, there is a growing need for novel stent technologies due to the rising prevalence of cardiovascular disorders, including hypertension, peripheral artery disease, and coronary artery disease.
  • Ageing PopulationAs the world’s population ages, cardiovascular problems are becoming more common, which is driving up demand for minimally invasive treatments like bioabsorbable stents.
  • Regulatory InitiativesThe development and licencing of bioabsorbable stents have been aided by regulatory bodies like the FDA and the European Medicines Agency (EMA), which have created a favourable regulatory climate for the market’s expansion.
  • Patient Preference for Minimally Invasive TreatmentsWhen compared to open procedures, patients are becoming more and more in favour of minimally invasive treatment choices that provide shorter recovery periods and a lower risk of problems.
  • Potential for Lower Healthcare expendituresBy reducing the need for recurrent procedures and related consequences, bioabsorbable stents have the potential to lower long-term healthcare expenditures, while potentially having higher upfront costs than typical metallic stents.
  • Growing Knowledge and Adoption by Medical ProfessionalsAs bioabsorbable stents become more widely used as a preferred treatment choice for patients who qualify, medical professionals are starting to recognise the advantages of these devices.

Global Fast- absorption Bioabsorbable Stents Market Restraints

Several factors can act as restraints or challenges for the Fast- absorption Bioabsorbable Stents Market. These may include

  • CostCompared to conventional metallic stents, theion of fast-absorption bioabsorbable stents is frequently more expensive. This increased expense can be a major deterrent, especially in areas with tight healthcare budgets or where patients would have to pay some of the bill out of pocket.
  • Low Clinical dataIn comparison to traditional metallic stents, the long-term clinical data for the safety and effectiveness of fast-absorption bioabsorbable stents may still be inadequate, despite encouraging early findings. These emerging technologies may cause physicians and patients to hesitate in their adoption due to a lack of solid facts.
  • Technical DifficultiesCreating bioabsorbable stents that absorb quickly and completely while maintaining ideal mechanical characteristics, such as enough radial strength and flexibility, and preventing side effects is a challenging task. It might also be concerning when patients’ absorption rates vary.
  • Obstacles related to regulationsThe approval procedures for stents and other medical devices can be onerous and time-consuming. Market introduction for fast-absorption bioabsorbable stents may be delayed if comprehensive clinical trials and proof of safety and efficacy are needed to get clearances.
  • Physician Knowledge and TrainingCompared to traditional metallic stents, fast-absorption bioabsorbable stents may require more training for physicians to correctly implant and manage. Market penetration may be hampered by resistance to implementing new methods or tools because of a comfort level with current procedures.
  • Competitive LandscapeEstablished firms hold a dominant position in the highly competitive stent industry. To effectively compete with existing goods, a new technology such as fast-absorption bioabsorbable stents requires a substantial investment in research, development, and marketing.
  • Patient Acceptance and SelectionCompared to traditional stents, patient acceptance requirements for fast-absorption bioabsorbable stents may be more stringent. The long-term durability and established track record of metallic stents may be preferred by certain patients and clinicians over the apparent advantages of bioabsorbable ones.
  • ComplicationsFast-absorbing bioabsorbable stents, like any medical device, have the potential to cause problems including restenosis, thrombosis, or damage to blood vessels. Market acceptability depends on addressing these concerns and making sure that patients are chosen and managed appropriately.

Global Fast- absorption Bioabsorbable Stents Market Segmentation Analysis

The Global Fast- absorption Bioabsorbable Stents Market is Segmented on the basis of By Application, By Material, By End User and Geography.

By Application

  • Coronary Artery Disease (CAD)With a large market share, coronary artery disease (CAD) is the most popular use for fast-absorption bioabsorbable stents. Stents are used to maintain the arteries providing blood to the heart open and enhance blood flow when CAD narrows them.
  • Peripheral Artery Disease (PAD)The ailment known as peripheral artery disease (PAD) causes the arteries in the arms and legs to narrow. Fast-absorption bioabsorbable stents are being utilised more often to treat PAD because they may be more advantageous than conventional metallic stents.
  • Additional UsesThe use of fast-absorption bioabsorbable stents is being studied for additional uses, including tracheal stenosis, ureteral strictures, and biliary tract strictures.

By Material

  • PolymersThe most popular material utilised in fast-absorption bioabsorbable stents is polymer. They may be made to decompose at various speeds and have high biocompatibility.
  • MetalsMetals like iron or magnesium are used to make some fast-absorbable bioabsorbable stents. Compared to polymer stents, these stents provide superior strength and support, but they could break down more quickly.

By End User

  • HospitalsBecause they have access to a wide range of treatment choices and highly qualified personnel, hospitals are the largest end-user of fast-absorbable bioabsorbable stents.
  • Ambulatory surgery centersThe need for fast-absorption bioabsorbable stents is being driven by these facilities’ growing availability of minimally invasive treatments, such as stent implantation

By Geography

  • North AmericaMarket conditions and demand in the United States, Canada, and Mexico.
  • EuropeAnalysis of the Fast- absorption Bioabsorbable Stents Market in European countries.
  • Asia-PacificFocusing on countries like China, India, Japan, South Korea, and others.
  • Middle East and AfricaExamining market dynamics in the Middle East and African regions.
  • Latin AmericaCovering market trends and developments in countries across Latin America.

Key Players

The major players in the Fast- absorption Bioabsorbable Stents Market are

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • REVA Medical
  • Biotronik SE & Co. KG
  • Kyoto Medical Planning Co.
  • Elixir Medical Corporation
  • Amaranth Medical
  • Arterial Remodeling Technologies
  • Tepha

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2020-2030

BASE YEAR

2023

FORECAST PERIOD

2024-2030

HISTORICAL PERIOD

2020-2022

UNIT

Value (USD Million)

KEY COMPANIES PROFILED

Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, REVA Medical, Biotronik SE & Co. KG, Kyoto Medical Planning Co., Elixir Medical Corporation, Amaranth Medical, Arterial Remodeling Technologies, Tepha

SEGMENTS COVERED

Application, Material, End User, And Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We dig deep, looking at the market from all angles – not just the money side, but the human side too, using both qualitative and quantitative analysis to break things down. You'll get the scoop on market size (in good ol' USD Billion!) for every slice and dice of the market. We'll point out where we expect the fastest growth and which areas will be king of the hill. We'll also break down each region, showing you where the product/service is being used and what's driving the market there. Plus, we'll give you the lowdown on the competition – who's on top, what new stuff they're launching, and who's partnering up or buying who. We're talking detailed company profiles, including overviews, insights, product comparisons, and even a SWOT analysis for the major players. Get ready for our take on where the market's headed, considering all the latest happenings (growth opportunities, what's holding things back) in both new and established markets. We'll even throw in a Porter's Five Forces analysis and walk you through the Value Chain to give you a complete picture. Finally, we'll lay out the market dynamics, highlight growth potential in the coming years, and top it off with 6 months of analyst support after you buy.

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.